Flexible nets: disorder and induced fit in the associations of p53 and 14-3-3 with their partners

Oldfield, Christopher J.; Jingwei Meng; Yang, Jack Y.; Qu Yang, Mary; Uversky, Vladimir N.; Dunker, A. Keith
January 2008
BMC Genomics;2008 Supplement 1, Vol. 9, Special section p1
Academic Journal
Background: Proteins are involved in many interactions with other proteins leading to networks that regulate and control a wide variety of physiological processes. Some of these proteins, called hub proteins or hubs, bind to many different protein partners. Protein intrinsic disorder, via diversity arising from structural plasticity or flexibility, provide a means for hubs to associate with many partners (Dunker AK, Cortese MS, Romero P, Iakoucheva LM, Uversky VN: Flexible Nets: The roles of intrinsic disorder in protein interaction networks. FEBS J 2005, 272:5129-5148). Results: Here we present a detailed examination of two divergent examples: 1) p53, which uses different disordered regions to bind to different partners and which also has several individual disordered regions that each bind to multiple partners, and 2) 14-3-3, which is a structured protein that associates with many different intrinsically disordered partners. For both examples, three-dimensional structures of multiple complexes reveal that the flexibility and plasticity of intrinsically disordered protein regions as well as induced-fit changes in the structured regions are both important for binding diversity. Conclusions: These data support the conjecture that hub proteins often utilize intrinsic disorder to bind to multiple partners and provide detailed information about induced fit in structured regions.


Related Articles

  • Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Strom, Evguenia; Sathe, Swati; Komarov, Pavel G.; Chernova, Olga B.; Pavlovska, Ivanda; Shyshynova, Inna; Bosykh, Dmitry A.; Burdelya, Lyudmila G.; Macklis, Roger M.; Skaliter, Rami; Komarova, Elena A.; Gudkov, Andrei V. // Nature Chemical Biology;Sep2006, Vol. 2 Issue 9, p474 

    p53-dependent apoptosis contributes to the side effects of cancer treatment, and genetic or pharmacological inhibition of p53 function can increase normal tissue resistance to genotoxic stress. It has recently been shown that p53 can induce apoptosis through a mechanism that does not depend on...

  • Serine 15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. Dumaz, Nicolas; Meek, David W. // EMBO Journal;12/15/99, Vol. 18 Issue 24, p7002 

    The p53 tumour suppressor protein is a labile transcription factor that is activated and stabilized in response to a wide range of cellular stresses, through a mechanism involving disruption of its interaction with MDM2, a negative regulatory partner. Induction of p53 by DNA damage additionally...

  • Probing Difference in Binding Modes of Inhibitors to MDMX by Molecular Dynamics Simulations and Different Free Energy Methods. Shi, Shuhua; Zhang, Shaolong; Zhang, Qinggang // PLoS ONE;29/10/2015, Vol. 10 Issue 10, p1 

    The p53-MDMX interaction has attracted extensive attention of anti-cancer drug development in recent years. This current work adopted molecular dynamics (MD) simulations and cross-correlation analysis to investigate conformation changes of MDMX caused by inhibitor bindings. The obtained...

  • Phosphorylation of ASPP2 by RAS/MAPK Pathway Is Critical for Its Full Pro-Apoptotic Function. Godin-Heymann, Nadia; Wang, Yihua; Slee, Elizabeth; Lu, Xin // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    We reported recently that apoptosis-stimulating protein of p53 (ASPP) 2, an activator of p53, co-operates with oncogenic RAS to enhance the transcription and apoptotic function of p53. However, the detailed mechanism remains unknown. Here we show that ASPP2 is a novel substrate of...

  • p53 mRNA controls p53 activity by managing Mdm2 functions. Candeias, Marco M.; Malbert-Colas, Laurence; Powell, Darren J.; Daskalogianni, Chrysoula; Mason, Magda .; Naski, Nadia; Bourougaa, Karima; Calvo, Fabien; Fåhraeus, Robin // Nature Cell Biology;Sep2008, Vol. 10 Issue 9, p1098 

    The E3 ubiquitin ligase Mdm2 is a focal regulator of p53 tumour suppressor activity. It binds p53, promoting its polyubiquitination and degradation, and also controls p53 synthesis. However, it is not known how this dual function of Mdm2 on p53 synthesis and degradation is achieved. Here we show...

  • Ribosomal protein S27L is a direct p53 target that regulates apoptosis. He, H.; Sun, Y. // Oncogene;4/26/2007, Vol. 26 Issue 19, p2707 

    Ribosomal proteins were recently shown to regulate p53 activity by abrogating Mdm2-induced p53 degradation (L23, L11, L5) or by enhancing p53 translation (L26). Here, we report that a novel ribosomal protein, RPS27L (S27-like protein), is a direct p53 target. RPS27L, but not its family member...

  • The Dose Window for Radiation-Induced Protective Adaptive Responses. Mitchel, Ronald E. J. // Dose-Response;2010, Vol. 8 Issue 2, p192 

    Adaptive responses to low doses of low LET radiation occur in all organisms thus far examined, from single cell lower eukaryotes to mammals. These responses reduce the deleterious consequences of DNA damaging events, including radiation-induced or spontaneous cancer and non-cancer diseases in...

  • A half-site of the p53-binding site on the keratin 14 promoter is specifically activated by p63. Cai, Bi-He; Chao, Chung-Faye; Lu, Mei-Hua; Lin, Hwang-Chi; Chen, Jang-Yi // Journal of Biochemistry;Jul2012, Vol. 152 Issue 1, p99 

    Three members of p53 family, p53, p63 and p73, can transactivate their specific target genes through a p53 consensus sequence-binding motif which consists with direct repeats of PuPuPuC(T/A)(T/A)GPyPyPy as a whole-site of p53-binding site. p63, an epidermal stem cells marker, can regulate...

  • Detection of TP53 R249 Mutation in Iranian Patients with Pancreatic Cancer. Mohamadkhani, Ashraf; Naderi, Elnaz; Sharafkhah, Maryam; Fazli, Hamid Reza; Moradzadeh, Malihe; Pourshams, Akram // Journal of Oncology;2013, p1 

    The TP53 gene encodes tumor protein p53 which play a major role in the etiology of pancreatic cancer. The important role of codon 249 of TP53 for binding of p53 to its sequence-specific consensus site in DNA has been revealed by crystallography's studies, and mutation at this codon was detected...


Other Topics